Robert Alexander
Directeur Technique/Scientifique/R&D chez Reunion Neuroscience, Inc.
Fortune : - $ au 31/07/2023
Profil
Robert Alexander is currently the Chief Medical Officer at Reunion Neuroscience, Inc. Prior to his current position, he obtained a doctorate degree from Pritzker School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. -.--% | 12/06/2023 | 0 ( -.--% ) | - $ | 31/07/2023 |
Postes actifs de Robert Alexander
| Sociétés | Poste | Début |
|---|---|---|
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Directeur Technique/Scientifique/R&D | 18/01/2023 |
Formation de Robert Alexander
| Pritzker School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
